抗胆固醇药对患有神经性下尿路功能障碍的患者的短期认知影响:系统性审查和元分析
1Department of Anesthesiology, First Affiliated Hospital of Huzhou University, Huzhou First People's Hospital, Huzhou, Zhejiang 313099, P.R. China.
Biomedical reports
|October 15, 2025
概括
对神经性下尿路功能障碍 (NLUTD) 的抗胆固醇药物可能会导致轻微的认知问题,特别是记忆和注意力问题. 然而,总体而言,短期效应在统计学上并不显著,因此需要进一步研究.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 神经性下尿路功能障碍 (NLUTD) 是神经系统疾病的常见并发症,通常用抗胆固醇药物治疗.
- 人们担心抗胆固醇药物可能导致NLUTD患者的认知障碍.
研究的目的:
- 在被诊断为NLUTD的患者中,系统地审查和元分析抗胆固醇药物的短期认知效应.
主要方法:
- 对相关的随机对照试验和观察性研究进行了PubMed,Embase,Cochrane图书馆和Scopus的系统搜索.
- 提取了研究特征,抗胆固醇剂,剂量和认知结果的数据.
- 采用随机效应模型来计算认知表现的聚合标准化平均差异 (SMD).
主要成果:
- 包含了三项研究,其中包括139名参与者. 对认知表现的整体聚合SMD为-0.33 (95%CI: -0.72至0.06;P=0.10),表明对负面影响的趋势不显著.
- 亚组分析显示,记忆力,执行功能和注意力显著受损,而全球认知指标显示变化很小.
- 在各个研究中观察到很高的异质性 (Q=162.25;P<0.001).
结论:
- 在NLUTD患者中短期使用抗胆固醇药物可能会对特定的认知领域产生不利影响,尽管整体影响在统计学上并不显著.
- 这些发现强调了需要仔细选择抗胆固醇药物的必要性,并强调了需要进行更大规模的研究来评估长期认知安全性.
- 应探索替代疗法,例如具有较少中心副作用的β3-上腺激动剂.
相关概念视频
Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Cholinergic Antagonists: Therapeutic Uses
1.3K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.3K
Cholinergic Antagonists: Pharmacokinetics
897
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
897
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.3K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K


